Yeast cells as an assay system for in vivo O-GlcNAc modification

O-GlcNAcylation is a reversible protein post-translational modification, where O-GlcNAc moiety is attached to nucleocytoplasmic protein by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA). Although O-GlcNAc modification widely occurs in eukaryotic cells, the budding yeast Saccharomyces ce...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1861; no. 5; pp. 1159 - 1167
Main Authors Nakanishi, Hideki, Li, Feng, Han, Baoxian, Arai, Seisuke, Gao, Xiao-Dong
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:O-GlcNAcylation is a reversible protein post-translational modification, where O-GlcNAc moiety is attached to nucleocytoplasmic protein by O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA). Although O-GlcNAc modification widely occurs in eukaryotic cells, the budding yeast Saccharomyces cerevisiae notably lacks this protein modification and the genes for the GlcNAc transferase and hydrolase. Human OGT isoforms and OGA were ectopically expressed in S. cerevisiae, and the effects of their expressions on yeast growth and O-GlcNAc modification levels were assessed. Expression of sOGT, in S. cerevisiae catalyzes the O-GlcNAc modification of proteins in vivo; conversely, the expression of OGA mediates the hydrolysis of these sugars. sOGT expression causes a severe growth defect in yeast cells, which is remediated by the co-expression of OGA. The direct analysis of yeast proteins demonstrates protein O-GlcNAcylation is dependent on sOGT expression; conversely, the hydrolysis of these sugar modifications is induced by co-expression of OGA. Protein O-GlcNAcylation and the growth defects of yeast cells are caused by the O-GlcNAc transferase activity because catalytically inactive sOGT does not exhibit toxicity in yeast cells. Expression of another OGT isoform, ncOGT, also results in a growth defect in yeast cells. However, its toxicity is largely attributed to the TPR domain rather than the O-GlcNAc transferase activity. O-GlcNAc cycling can occur in yeast cells, and OGT and OGA activities can be monitored via yeast growth. Yeast cells may be used to assess OGT and OGA. •Expression of sOGT can inhibit yeast growth depending on its O-GlcNAc transferase activity.•Expression of OGT in yeast induces O-GlcNAcylation of endogenous yeast proteins.•OGT and OGA activities can be monitored through yeast cell growth.•Expression of ncOGT also causes a growth defect in yeast cells but its toxicity is largely attributed to the TPR domain.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
1872-8006
DOI:10.1016/j.bbagen.2017.03.002